Kyle W Becker

Kyle W Becker

Vanderbilt University

H-index: 14

North America-United States

About Kyle W Becker

Kyle W Becker, With an exceptional h-index of 14 and a recent h-index of 14 (since 2020), a distinguished researcher at Vanderbilt University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

A Nanoparticle RIG-I Agonist for Cancer Immunotherapy

A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists

Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists

Kyle W Becker Information

University

Position

___

Citations(all)

1322

Citations(since 2020)

1135

Cited By

515

hIndex(all)

14

hIndex(since 2020)

14

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Top articles of Kyle W Becker

Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy

ACS nano

2024/4/23

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

ACS nano

2024/2/22

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Science Immunology

2023/5/5

A Nanoparticle RIG-I Agonist for Cancer Immunotherapy

bioRxiv

2023

A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA

Journal of Controlled Release

2022/5/1

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Journal of controlled release

2021/2/10

Kyle W Becker
Kyle W Becker

H-Index: 8

Jessalyn J Baljon
Jessalyn J Baljon

H-Index: 6

Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists

Advanced healthcare materials

2021/1

Kyle W Becker
Kyle W Becker

H-Index: 8

Christian R Palmer
Christian R Palmer

H-Index: 3

Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists

ACS Central Science

2020/10/26

Kyle W Becker
Kyle W Becker

H-Index: 8

Christian R Palmer
Christian R Palmer

H-Index: 3

At the bench: Engineering the next generation of cancer vaccines

2020/10

Jessalyn J Baljon
Jessalyn J Baljon

H-Index: 6

Kyle W Becker
Kyle W Becker

H-Index: 8

Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines

ACS nano

2020/7/23

See List of Professors in Kyle W Becker University(Vanderbilt University)

Co-Authors

academic-engine